Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats

被引:41
作者
Al-Majed, Abdulhakeem A. [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmacol, Riyadh 11451, Saudi Arabia
关键词
PERFORMANCE LIQUID-CHROMATOGRAPHY; PROPIONYL-L-CARNITINE; ACETYL-L-CARNITINE; PROCAINAMIDE HYDROCHLORIDE; INDUCED NEPHROTOXICITY; NITRIC-OXIDE; TISSUE; DAMAGE; LIVER; CHEMOTHERAPY;
D O I
10.1111/j.1742-7843.2006.00024.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study investigates whether or not carnitine deficiency is a risk factor and could contribute to cisplatin-induced liver toxicity. A total of 60 adult male Wistar albino rats were divided into six groups. The first three groups were injected intraperitoneally with normal saline, propionyl-L-carnitine (500 mg/kg), and D-carnitine (500 mg/kg), respectively, for 10 successive days. The fourth, fifth and sixth groups were injected intraperitoneally with the same doses of normal saline, propionyl-L-carnitine and D-carnitine, respectively, for 5 successive days before and after a single dose of cisplatin (7 mg/kg). Administration of the standard nephrotoxic dose of cisplatin did not produce any changes in serum alanine transaminase and gamma-glutamyl transferase and no morphological changes in liver tissues. However, it did produce a significant increase in thiobarbituric acid reactive substances and total nitrate/nitrite and a significant decrease in reduced glutathione content in liver tissues. On the other hand, combined treatment with cisplatin and D-carnitine induced a dramatic increase in serum alanine transaminase and gamma-glutamyl transferase, as well as progressive reduction in total carnitine and ATP content in liver tissue. Moreover, histopathological examination of liver tissues confirmed the biochemical data, where cisplatin and D-carnitine combination showed signs of liver injury manifested as focal necro-inflammatory changes and portal inflammation. Interestingly, in carnitine supplemented rats using propionyl-L-carnitine, cisplatin did not produce any biochemical and histopathological changes in liver tissues. In conclusion, data from this study suggest for the first time that (1) carnitine deficiency is a risk factor and could precipitate cisplatin-induced hepatotoxicity, (2) oxidative stress is not the main cause of cisplatin-related hepatotoxicity and (3) propionyl-L-carnitine prevents the development of cisplatin-induced liver injury.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 36 条
  • [31] Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatin
    Watanabe, K
    Hess, A
    Bloch, W
    Michel, O
    [J]. ANTI-CANCER DRUGS, 2000, 11 (01) : 29 - 32
  • [33] Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice
    Yasui, F
    Matsugo, S
    Ishibashi, M
    Kajita, T
    Ezashi, Y
    Oomura, Y
    Kojo, S
    Sasaki, K
    [J]. NEUROSCIENCE LETTERS, 2002, 334 (03) : 177 - 180
  • [34] Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats
    Yildirim, Z
    Sogut, S
    Odaci, E
    Iraz, M
    Ozyurt, H
    Kotuk, M
    Akyol, O
    [J]. PHARMACOLOGICAL RESEARCH, 2003, 47 (02) : 149 - 156
  • [35] The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester
    Yilmaz, HR
    Sogut, S
    Ozyurt, B
    Ozugurlu, F
    Sahin, S
    Isik, B
    Uz, E
    Ozyurt, H
    [J]. TOXICOLOGY AND INDUSTRIAL HEALTH, 2005, 21 (3-4) : 67 - 73
  • [36] Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats
    Zicca, A
    Cafaggi, S
    Mariggiò, MA
    Vannozzi, MO
    Ottone, M
    Bocchini, V
    Caviglioli, G
    Viale, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 442 (03) : 265 - 272